PARSIPPANY, N.J.–(BUSINESS WIRE)–Zoetis today announced that the U.S. Food and Drug Administration (FDA) has approved Simparica TrioTM (sarolaner, moxidectin, and pyrantel chewable tablets), the first once-monthly, chewable tablet in the U.S. that delivers all-in-one protection from heartworm disease, ticks and fleas, roundworms and hookworms. This combination product builds on the trusted legacy of Simparica® (sarolaner) Chewables and exemplifies Zoetis’ dedication to innovation in parasiticides.
